10-Q Filing

OPTION CARE HEALTH, INC. CIK: 1014739 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001014739-15-000017`
Period End Date	20150930
Filing Date	20151104
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	bios-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 98 Income Statement 112 Cash Flow Statement 98 Stockholders Equity 19

Balance Sheet 98 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$70.11M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$66.50M	USD	Point-in-time
Temporary Equity, Par or Stated Value Per Share (in dollars per share)	`TemporaryEquityParOrStatedValuePerShare`	-	USD	Point-in-time
Temporary Equity, Par or Stated Value Per Share (in dollars per share)	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Temporary Equity, Liquidation Preference	`TemporaryEquityLiquidationPreference`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$740.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.44M	USD	Point-in-time
Temporary Equity, Liquidation Preference	`TemporaryEquityLiquidationPreference`	$66.66M	USD	Point-in-time
Temporary Equity, Shares Authorized (in shares)	`TemporaryEquitySharesAuthorized`	0.00	shares	Point-in-time
Receivables, less allowance for doubtful accounts of $70,107 and $66,405 as of September 30, 2015 and December 31, 2014, respectively	`ReceivablesNetCurrent`	$131.66M	USD	Point-in-time
Receivables, less allowance for doubtful accounts of $70,107 and $66,405 as of September 30, 2015 and December 31, 2014, respectively	`ReceivablesNetCurrent`	$121.19M	USD	Point-in-time
Temporary Equity, Shares Authorized (in shares)	`TemporaryEquitySharesAuthorized`	825,000.00	shares	Point-in-time
Series A preferred stock, shares issued (in shares)	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Inventory	`InventoryNet`	$37.22M	USD	Point-in-time
Inventory	`InventoryNet`	$26.89M	USD	Point-in-time
Series A preferred stock, shares issued (in shares)	`TemporaryEquitySharesIssued`	635,832.00	shares	Point-in-time
Series A preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Series A preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	635,832.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.05M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$21.89M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$9.55M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Preferred Stock, Shares Authorized (in shares)	`PreferredStockSharesAuthorized`	4.17M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$199.41M	USD	Point-in-time
Preferred Stock, Shares Authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$188.22M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$38.17M	USD	Point-in-time
Preferred Stock, Shares Issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$34.11M	USD	Point-in-time
Preferred Stock, Shares Outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Goodwill	`Goodwill`	$560.58M	USD	Point-in-time
Preferred Stock, Shares Outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Goodwill	`Goodwill`	$308.73M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$10.27M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$6.00M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common Stock, Shares Authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$13.24M	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$13.46M	USD	Point-in-time
Common Stock, Shares, Issued (in shares)	`CommonStockSharesIssued`	71.27M	shares	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.16M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.27M	USD	Point-in-time
Common Stock, Shares, Issued (in shares)	`CommonStockSharesIssued`	71.40M	shares	Point-in-time
Common Stock, Shares, Outstanding (in shares)	`CommonStockSharesOutstanding`	68.64M	shares	Point-in-time
Common Stock, Shares, Outstanding (in shares)	`CommonStockSharesOutstanding`	68.75M	shares	Point-in-time
Non-current assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$12.74M	USD	Point-in-time
Non-current assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	-	USD	Point-in-time
Total assets	`Assets`	$562.66M	USD	Point-in-time
Total assets	`Assets`	$824.71M	USD	Point-in-time
Treasury Stock, Shares (in shares)	`TreasuryStockShares`	2.64M	shares	Point-in-time
Treasury Stock, Shares (in shares)	`TreasuryStockShares`	2.65M	shares	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$39.59M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$5.39M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$89.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$53.38M	USD	Point-in-time
Amounts due to plan sponsors	`AmountsDueToPlanSponsors`	$3.51M	USD	Point-in-time
Amounts due to plan sponsors	`AmountsDueToPlanSponsors`	$4.87M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$6.85M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$2.27M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$48.08M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$46.02M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$9.98M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$162.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$146.84M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$409.33M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$418.41M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesGrossNoncurrent`	$19.06M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesGrossNoncurrent`	$56.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$8.13M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$6.79M	USD	Point-in-time
Total liabilities	`Liabilities`	$607.91M	USD	Point-in-time
Total liabilities	`Liabilities`	$563.01M	USD	Point-in-time
Series A convertible preferred stock, $.0001 par value; 825,000 shares authorized; 635,822 shares issued and outstanding; and, $66,657 liquidation preference as of September 30, 2015. No convertible preferred stock was authorized or outstanding as of December 31, 2014.	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Series A convertible preferred stock, $.0001 par value; 825,000 shares authorized; 635,822 shares issued and outstanding; and, $66,657 liquidation preference as of September 30, 2015. No convertible preferred stock was authorized or outstanding as of December 31, 2014.	`TemporaryEquityCarryingAmountAttributableToParent`	$60.78M	USD	Point-in-time
Preferred stock, $.0001 par value; 4,175,000 and 5,000,000 shares authorized as of September 30, 2015 and December 31, 2014, respectively; no shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.0001 par value; 4,175,000 and 5,000,000 shares authorized as of September 30, 2015 and December 31, 2014, respectively; no shares issued and outstanding as of September 30, 2015 and December 31, 2014, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.0001 par value; 125,000,000 shares authorized; 71,401,664 and 71,274,064 shares issued and 68,747,613 and 68,636,965 shares outstanding as of September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock, $.0001 par value; 125,000,000 shares authorized; 71,401,664 and 71,274,064 shares issued and 68,747,613 and 68,636,965 shares outstanding as of September 30, 2015 and December 31, 2014, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Treasury stock, 2,654,051 and 2,637,099 shares at cost as of September 30, 2015 and December 31, 2014, respectively	`TreasuryStockValue`	$10.74M	USD	Point-in-time
Treasury stock, 2,654,051 and 2,637,099 shares at cost as of September 30, 2015 and December 31, 2014, respectively	`TreasuryStockValue`	$10.68M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$533.06M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$529.68M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-583.47M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-302.21M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$216.81M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$354.58M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-61.14M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$278.53M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$824.71M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$562.66M	USD	Point-in-time

Income Statement 112 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`HealthCareOrganizationOtherRevenue`	$226.42M	USD	1 Quarter
Product revenue	`HealthCareOrganizationOtherRevenue`	$667.60M	USD	3 Qtrs
Product revenue	`HealthCareOrganizationOtherRevenue`	$240.85M	USD	1 Quarter
Product revenue	`HealthCareOrganizationOtherRevenue`	$720.91M	USD	3 Qtrs
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$5.04M	USD	1 Quarter
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$6.38M	USD	1 Quarter
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$15.31M	USD	3 Qtrs
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$17.57M	USD	3 Qtrs
Total revenue	`HealthCareOrganizationRevenue`	$682.91M	USD	3 Qtrs
Total revenue	`HealthCareOrganizationRevenue`	$231.46M	USD	1 Quarter
Total revenue	`HealthCareOrganizationRevenue`	$247.22M	USD	1 Quarter
Total revenue	`HealthCareOrganizationRevenue`	$738.48M	USD	3 Qtrs
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$526.86M	USD	3 Qtrs
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$162.12M	USD	1 Quarter
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$475.52M	USD	3 Qtrs
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$176.15M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$25.53M	USD	3 Qtrs
Cost of service revenue	`CostOfServices`	$8.57M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$7.93M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$23.40M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$501.05M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$170.69M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$550.25M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$184.08M	USD	1 Quarter
Gross profit	`GrossProfit`	$60.77M	USD	1 Quarter
Gross profit	`GrossProfit`	$188.22M	USD	3 Qtrs
Gross profit	`GrossProfit`	$63.14M	USD	1 Quarter
Gross profit	`GrossProfit`	$181.86M	USD	3 Qtrs
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$166.66M	USD	3 Qtrs
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$53.60M	USD	1 Quarter
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$167.47M	USD	3 Qtrs
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$56.09M	USD	1 Quarter
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	$-51.00K	USD	1 Quarter
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	$6.94M	USD	3 Qtrs
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	$86.00K	USD	1 Quarter
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	$21.00K	USD	3 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$26.08M	USD	1 Quarter
Bad debt expense	`ProvisionForDoubtfulAccounts`	$41.05M	USD	3 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$32.83M	USD	3 Qtrs
Bad debt expense	`ProvisionForDoubtfulAccounts`	$9.32M	USD	1 Quarter
Impairment of goodwill	`GoodwillImpairmentLoss`	$13.85M	USD	1 Quarter
Impairment of goodwill	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Impairment of goodwill	`GoodwillImpairmentLoss`	$251.85M	USD	3 Qtrs
Impairment of goodwill	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$274.00K	USD	1 Quarter
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$2.92M	USD	1 Quarter
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$14.75M	USD	3 Qtrs
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$753.00K	USD	3 Qtrs
Restructuring and other expenses	`RestructuringCharges`	$12.31M	USD	3 Qtrs
Restructuring and other expenses	`RestructuringCharges`	$4.04M	USD	1 Quarter
Restructuring and other expenses	`RestructuringCharges`	$1.85M	USD	1 Quarter
Restructuring and other expenses	`RestructuringCharges`	$10.30M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$4.26M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.62M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$4.94M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.29M	USD	1 Quarter
Loss from continuing operations	`OperatingIncomeLoss`	$-281.23M	USD	3 Qtrs
Loss from continuing operations	`OperatingIncomeLoss`	$-27.71M	USD	1 Quarter
Loss from continuing operations	`OperatingIncomeLoss`	$-19.28M	USD	1 Quarter
Loss from continuing operations	`OperatingIncomeLoss`	$-48.90M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-9.57M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-27.75M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-29.20M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-9.51M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-78.10M	USD	3 Qtrs
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-28.79M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-37.27M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-308.98M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$1.93M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-4.55M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$8.48M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-22.54M	USD	3 Qtrs
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-24.24M	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-286.44M	USD	3 Qtrs
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-39.20M	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-86.58M	USD	3 Qtrs
Income from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$494.00K	USD	1 Quarter
Income from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$7.46M	USD	1 Quarter
Income from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$5.17M	USD	3 Qtrs
Income from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$2.74M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-16.78M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-38.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-281.26M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-83.84M	USD	3 Qtrs
Accrued dividends on preferred stock	`TemporaryEquityDividendsAdjustment`	$4.16M	USD	3 Qtrs
Accrued dividends on preferred stock	`TemporaryEquityDividendsAdjustment`	-	USD	3 Qtrs
Accrued dividends on preferred stock	`TemporaryEquityDividendsAdjustment`	$1.90M	USD	1 Quarter
Accrued dividends on preferred stock	`TemporaryEquityDividendsAdjustment`	-	USD	1 Quarter
Deemed dividends on preferred stock	`TemporaryEquityAccretionToRedemptionValueAdjustment`	$169.00K	USD	1 Quarter
Deemed dividends on preferred stock	`TemporaryEquityAccretionToRedemptionValueAdjustment`	-	USD	1 Quarter
Deemed dividends on preferred stock	`TemporaryEquityAccretionToRedemptionValueAdjustment`	$3.52M	USD	3 Qtrs
Deemed dividends on preferred stock	`TemporaryEquityAccretionToRedemptionValueAdjustment`	-	USD	3 Qtrs
Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-288.94M	USD	3 Qtrs
Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-18.85M	USD	1 Quarter
Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-38.71M	USD	1 Quarter
Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-83.84M	USD	3 Qtrs
Loss from continuing operations, basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-1.27	USD	3 Qtrs
Loss from continuing operations, basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.57	USD	1 Quarter
Loss from continuing operations, basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-4.28	USD	3 Qtrs
Loss from continuing operations, basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.38	USD	1 Quarter
Income from discontinued operations, basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.04	USD	3 Qtrs
Income from discontinued operations, basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.01	USD	1 Quarter
Income from discontinued operations, basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.08	USD	3 Qtrs
Income from discontinued operations, basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$0.11	USD	1 Quarter
Loss per common share, basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-4.20	USD	3 Qtrs
Loss per common share, basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.56	USD	1 Quarter
Loss per common share, basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Loss per common share, basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.23	USD	3 Qtrs
Weighted average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	68.74M	shares	1 Quarter
Weighted average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	68.69M	shares	3 Qtrs
Weighted average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	68.61M	shares	1 Quarter
Weighted average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	68.42M	shares	3 Qtrs

Cash Flow Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-16.78M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-38.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-281.26M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-83.84M	USD	3 Qtrs
Less: income from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$494.00K	USD	1 Quarter
Less: income from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$7.46M	USD	1 Quarter
Less: income from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$5.17M	USD	3 Qtrs
Less: income from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$2.74M	USD	3 Qtrs
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-24.24M	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-286.44M	USD	3 Qtrs
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-39.20M	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-86.58M	USD	3 Qtrs
Depreciation	`Depreciation`	$12.46M	USD	3 Qtrs
Depreciation	`Depreciation`	$4.03M	USD	1 Quarter
Depreciation	`Depreciation`	$4.21M	USD	1 Quarter
Depreciation	`Depreciation`	$12.00M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$4.26M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.62M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$4.94M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.29M	USD	1 Quarter
Impairment of goodwill	`GoodwillImpairmentLoss`	$13.85M	USD	1 Quarter
Impairment of goodwill	`GoodwillImpairmentLoss`	-	USD	3 Qtrs
Impairment of goodwill	`GoodwillImpairmentLoss`	$251.85M	USD	3 Qtrs
Impairment of goodwill	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$2.93M	USD	3 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$3.61M	USD	3 Qtrs
Change in fair value of contingent consideration	`IncreaseDecreaseinFairValueofContingentConsideration`	$21.00K	USD	3 Qtrs
Change in fair value of contingent consideration	`IncreaseDecreaseinFairValueofContingentConsideration`	$6.94M	USD	3 Qtrs
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$21.21M	USD	3 Qtrs
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-8.22M	USD	3 Qtrs
Compensation under stock-based compensation plans	`ShareBasedCompensation`	$6.64M	USD	3 Qtrs
Compensation under stock-based compensation plans	`ShareBasedCompensation`	$3.65M	USD	3 Qtrs
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-784.00K	USD	3 Qtrs
Loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Receivables, net of bad debt expense	`IncreaseDecreaseInReceivables`	$2.39M	USD	3 Qtrs
Receivables, net of bad debt expense	`IncreaseDecreaseInReceivables`	$-3.62M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-486.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-10.33M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.39M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-5.92M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$12.04M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-35.82M	USD	3 Qtrs
Amounts due to plan sponsors	`IncreaseDecreaseinAmountsDueToPlanSponsor`	$-1.35M	USD	3 Qtrs
Amounts due to plan sponsors	`IncreaseDecreaseinAmountsDueToPlanSponsor`	$2.14M	USD	3 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$-4.59M	USD	3 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$436.00K	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-8.55M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-553.00K	USD	3 Qtrs
Net cash used in operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-40.04M	USD	3 Qtrs
Net cash used in operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-71.47M	USD	3 Qtrs
Net cash provided by operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$4.06M	USD	3 Qtrs
Net cash provided by operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$8.29M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-31.75M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-67.41M	USD	3 Qtrs
Purchases of property and equipment, net	`PaymentsForProceedsFromProductiveAssets`	$9.36M	USD	3 Qtrs
Purchases of property and equipment, net	`PaymentsForProceedsFromProductiveAssets`	$11.32M	USD	3 Qtrs
Cash consideration paid for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Cash consideration paid for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$454.00K	USD	3 Qtrs
Net cash used in investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-11.77M	USD	3 Qtrs
Net cash used in investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-9.36M	USD	3 Qtrs
Net cash provided by investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$22.38M	USD	3 Qtrs
Net cash provided by investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$57.68M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$13.02M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.90M	USD	3 Qtrs
Proceeds from issuance of convertible preferred stock and warrants, net of issuance costs	`ProceedsfromIssuanceofConvertiblePreferredStockandWarrants`	$59.69M	USD	3 Qtrs
Proceeds from issuance of convertible preferred stock and warrants, net of issuance costs	`ProceedsfromIssuanceofConvertiblePreferredStockandWarrants`	-	USD	3 Qtrs
Proceeds from senior notes due 2021, net of fees paid to lenders	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	3 Qtrs
Proceeds from senior notes due 2021, net of fees paid to lenders	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$193.85M	USD	3 Qtrs
Deferred and other financing costs	`PaymentsOfFinancingCosts`	$2.12M	USD	3 Qtrs
Deferred and other financing costs	`PaymentsOfFinancingCosts`	$1.22M	USD	3 Qtrs
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	$203.66M	USD	3 Qtrs
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	$205.70M	USD	3 Qtrs
Repayments on line of credit	`RepaymentsOfLongTermLinesOfCredit`	$178.66M	USD	3 Qtrs
Repayments on line of credit	`RepaymentsOfLongTermLinesOfCredit`	$241.20M	USD	3 Qtrs
Principal payments on long-term debt	`ProceedsFromRepaymentsOfSecuredDebt`	-	USD	3 Qtrs
Principal payments on long-term debt	`ProceedsFromRepaymentsOfSecuredDebt`	$-172.24M	USD	3 Qtrs
Repayments of capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$248.00K	USD	3 Qtrs
Repayments of capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$315.00K	USD	3 Qtrs
Net proceeds from exercise of employee stock compensation plans	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Net proceeds from exercise of employee stock compensation plans	`ProceedsFromStockOptionsExercised`	$1.10M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-59.00K	USD	3 Qtrs
Net cash provided by (used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivities`	$-15.16M	USD	3 Qtrs
Net cash provided by (used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivities`	$83.10M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$28.70M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.00M	USD	3 Qtrs
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$740.00K	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$29.44M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$740.00K	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$29.44M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$25.33M	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$23.88M	USD	3 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaidNet`	$1.69M	USD	3 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaidNet`	$462.00K	USD	3 Qtrs

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$216.81M	USD	Point-in-time
Balance	`StockholdersEquity`	$354.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$-61.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$278.53M	USD	Point-in-time
Issuance of Series A convertible preferred stock and warrants	`AdjustmentstoAdditionalPaidinCapitalPrivateInvestmentinPublicEquityTransaction`	$6.58M	USD	3 Qtrs
Accrued dividends on preferred stock	`AdjustmentstoAdditionalPaidinCapitalIncreaseinLiquidationPreferenceonTemporaryEquity`	$4.16M	USD	3 Qtrs
Deemed dividends on preferred stock	`AdjustmentstoAdditionalPaidinCapitalAccretionofDiscountonTemporaryEquity`	$3.51M	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.10M	USD	3 Qtrs
Compensation under employee stock compensation plan	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.47M	USD	3 Qtrs
Compensation under employee stock compensation plan	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.69M	USD	3 Qtrs
Surrender of stock to satisfy minimum tax withholding	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$56.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-16.78M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-38.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-281.26M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-83.84M	USD	3 Qtrs
Balance	`StockholdersEquity`	$216.81M	USD	Point-in-time
Balance	`StockholdersEquity`	$354.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$-61.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$278.53M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.